Viewing Study NCT00064792

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:15 PM
Ignite Modification Date: 2026-05-18 @ 12:02 PM
Study NCT ID: NCT00064792
Status: COMPLETED
Last Update Posted: 2014-06-06
First Post: 2003-07-11
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Simvastatin Therapy in Smith-Lemli-Opitz Syndrome
Sponsor: Forbes Porter, M.D.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Smith-Lemli-Opitz Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cholesterol View
None SLOS View
None HMG-COA Reductase Inhibitor View
None Malformation Syndrome View
None Mental Retardation View
None Smith-Lemli-Opitz Syndrome View